Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CYTKCYTK
Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in CYTOKINETICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 1.6M shares of CYTK (CYTOKINETICS INC), worth $133.4M as of 2026-Q2. The position was increased (+12.1% shares). CYTK represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$133.4M

Current Shares

1.6M

Total Value Change

+$63.6M

Total Shares Change

+244,390

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+12.1%
$133.4M0.0%$85.19
34
2026-Q1
Increased
1.4M
+1.0%
$92.1M0.0%$65.91
30
2025-Q4
Increased
1.4M
+0.7%
$87.9M0.0%$63.54
30
2025-Q3
Increased
1.4M
+1.2%
$75.5M0.0%$54.96
30
2025-Q2
Increased
1.4M
+3.4%
$44.8M0.0%$33.04
30
2025-Q1
Decreased
1.3M
-1.7%
$52.8M0.0%$40.19
0
2024-Q4
Increased
1.3M
+1.0%
$62.8M0.0%$47.04
30
2024-Q3
Increased
1.3M
+42.8%
$69.8M0.0%$52.80
40

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used